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ABSTRACT  Concanavalin A  (Con  A)  has been  used  to activate  platelets,  inducing a specific 
interaction between the glycoprotein  lib-Ilia complex and the cytoskeleton of the activated 
platelet, in agreement with this, we have shown that Con A activates human ptatelets, initiating 
phosphorylation, secretion, and cytoskeletal formation. Con A and cytochalasin B were used 
to demonstrate a reciprocal  interaction of the glycoprotein  complex with  the  platelet cyto- 
skeleton. Additionally, we have shown that a similar  reciprocity is provided by the multivalent 
fibrin-fibrinogen  platelet interaction found in the thrombin-induced clot. Con A differs from 
other activators  in  precipitating an apparent cytoskeletal core despite a complete  inhibition 
of platelet activation  by prostaglandin  El.  We  suggest, from  this  result,  that Con A  may be 
cross-linking a membrane-associated cytoskeletal complex present in the unactivated platelet. 
Concanavalin A (Con A),~ A multivalent lectin, has been used 
to demonstrate transmembranous receptor-cytoskeleton in- 
teractions in  fibroblasts (1),  lymphocytes (2),  and adenocar- 
cinoma cell lines (3).  In addition,  Con  A  binds to  platelet 
surface glycoproteins, especially each component of the gly- 
coprotein IIb-IIIa  complex (4). The tetrameric Con A mole- 
cule, as well as other multivalent lectins, also activates platelets 
by an as yet unknown  mechanism (5).  It has been proposed 
that  Con  A  activation leads to  cytosolic calcium elevation 
with  subsequent  protein  phosphorylation  and  cytoskeletal 
core formation in the same manner as thrombin or arachi- 
donate (6). Painter et al. (7) have reported that Con A induces 
a specific transmembranous interaction between the glycopro- 
rein  llb-IIIa receptor complex and  the  cytoskeleton  of the 
activated platelet. This interaction is more extensive than that 
seen  with  typical platelet activators in  that  85-90%  of the 
surface-labeled glycoprotein lib-Ilia complex is  retained  in 
the  Con  A-induced  cytoskeletal  core,  whereas  thrombin- 
aggregated platelets retain only ~26% of this complex (8). 
The terms contractile gel  and  pseudopodal cytoskeletons 
have been ultrastructurally defined as the dense microfilament 
network responsible for platelet secretory granule centraliza- 
tion and the parallel microfilament bundles observed in plate- 
~Abbreviations  used  in  this paper.  Con  A,  concanavalin  A;  CB, 
cytochalasin B; PGEj, prostaglandin El. 
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let pseudopodia (9).  These cytoskeletal structures resist non- 
ionic detergent extraction and can be collected as cytoskeletal 
cores which,  remarkably, retain the ultrastructural form ob- 
served in the intact platelet (8). 
Our previous studies have shown that  the  contractile gel 
and  pseudopodia can  be separately assembled with  unique 
cytoskeletal core  components (9).  In  the  presence of cyto- 
chalasin B (CB), the activated platelets form a contractile gel 
and secrete granules normally but have limited pseudopodal 
development, as observed by transmission electron micros- 
copy. Although CB did not affect the extent of actin polym- 
erization  or actin-binding  protein  phosphorylation,  we  ob- 
serve an almost complete loss of actin-binding protein  and 
about half of the actin from the detergent extract. There was 
also  a  comparable loss  of alpha-actinin  and  tropomyosin, 
which were not quantitated in this study. Under these condi- 
tions, the cytoskeletal core consisted of actin-tropomyosin, 
alpha-actinin, and an unreduced quantity of myosin. 
Our conclusion from these studies was that CB was pre- 
venting the  formation of long actin filaments which,  when 
cross-linked by actin-binding protein, made up the pseudo- 
podal  cytoskeleton.  The question  of whether  or  not  actin- 
binding protein was interacting with the nonsedimenting fi- 
lamentous actin was not resolved in this study. 
More recently, we have shown that  the glycoprotein IIb- 
IIIa complex, which  forms the  fibrinogen  binding  site  ex- 
993 pressed upon platelet activation, is specifically  linked to the 
CB-sensitive pseudopodal cytoskeleton (10). This conclusion 
is also based on the observation that retention of the glyco- 
protein IIb-IIIa complex in the detergent-insoluble core is not 
observed when platelets are activated in the presence of CB. 
Again,  we attribute this to an inhibition by CB of long actin 
filament  formation,  since  fibrinogen  binding  and  platelet 
aggregation dependent on the glycoprotein IIb-IIIa complex 
were not blocked by CB.  This left open the possibility that 
linkages  between  glycoprotein lib-Ilia  complexes and  the 
nonsedimenting  actin-binding  protein-actin  filaments  still 
occurred but that such complexes were insufficiently cross- 
linked to precipitate after detergent extraction. Although the 
exact nature of this linkage and its importance to the expres- 
sion of the fibrinogen binding site is unknown, we did deter- 
mine in this study that receptor occupancy alone was insuf- 
ficient to retain the complex in the isolated cytoskeletal core. 
Rather, a multivalent interaction with these surface receptors 
is required to stabilize their interaction with the cytoskeleton. 
This  entire  cytoskeletal assembly  process of actin  poly- 
merization and interaction with phosphorylated myosin and 
actin-binding protein can be completely reversed by agents 
that elevate platelet cytosolic cyclic AMP levels (11,  12). This 
oppositional control is  most  likely due to the  lowering of 
cytosolic calcium levels elevated during activation (13). More- 
over, these  studies  showed that  the  cytoskeletal assembly- 
disassembly cycles correlated completely with the reversal of 
platelet  shape  change,  aggregation,  and  expression  of the 
fibrinogen binding site. 
In this study, we have used Con A and CB to demonstrate 
a reciprocal interaction of the glycoprotein IIb-llIa complex 
with platelet pseudopodal elements. Moreover, using prosta- 
glandin  E~  (PGEI) and  the  reciprocal Con  A-cytoskeleton 
interaction, we demonstrate a membrane-associated cytoskel- 
etal complex that may be pre-organized in the unactivated 
platelet.  Evidence is  also  presented  that  the  physiological 
correlate to the multivalent binding of Con A  may be the 
fibrin-fibrinogen-platelet interaction found in the  forming 
thrombin-induced clot. 
MATERIALS  AND  METHODS 
Lyophilized  human fibrinogen was purchased  from Helena  Laboratories, 
Beaumont, TX. [t4C]5-Hydroxytryptamine (serotonin) and carrier-free Na~251 
were obtained  from Amersham,  Radiochemica  Center, Amersham,  England. 
32p-Orthophosphate was obtained  from New England Nuclear,  Boston, MA. 
Sigma Chemical Co., St. Louis, MO, supplied the bovine serum albumin (BSA), 
Con A, Con A-Sepharose 4B-CL, Triton X-100, glucose oxidase, Sepharose 2B, 
PGE~, and CB.  Thrombin was a generous gift from Dr.  Charles T.  Esmon 
(Oklahoma  Medical Research Foundation).  Lyophilized lactoperoxidase was 
purchased  from Calbiochem-Behring  Corp.,  La  Jolla,  CA.  Electrophoresis 
reagents and the high molecular  weight standard  protein  mixture  were pur- 
chased from Bio-Rad Laboratories, Richmond,  CA. 
Preparation of Get-filtered Platelets:  Blood,  obtained by stand- 
ard  venipuncture  techniques  from  normal drug-free human volunteers,  was 
drawn  into  0.1  vol of 100  mM citrate  acid and  130 mM glucose (pH 6.5). 
Platelet-rich plasma was separated by centrifugation of the blood at 1,000 g for 
3 min at room temperature,  and platelets were pelleted by centrifugation  as 
previously described (9). Platelets for surface iodination  were resuspended in 
Tangen-HEPES (145 mM sodium chloride, 5 mM potassium chloride, 0.1 mM 
magnesium chloride, 0.05 mM calcium chloride, 5.5 mM glucose, and 15 mM 
HEPES. pH 7.4) with the addition of 1 t~g/ml POEt. Platelet surface membrane 
proteins  were radiolabeled  with  t25I by lactoperoxidase-catalyzed  iodination 
before gel filtration as previously described (10), Platelets for phosphorylation 
studies were resuspended  in Tangen-HEPES  buffer with  1 mg/ml BSA and 
allowed to incorporate 32p-orthophosphate ( I mCi/ml) for 45 rain at 37"C (9). 
Platelets for secretion studies were similarly resuspended and incubated  with 
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0.05 #Ci/ml [t4C]serotonin added for the last 20 min. Residual plasma proteins 
and  unincorporated  label (t25I, 14C, or 32p) were removed by gel filtration at 
4"C on a Sepharose 2B column equilibrated and eluted with Tangen-HEPES- 
BSA ( 1 mg/ml). After gel filtration, the final platelet concentration was adjusted 
to 5 x  l0  g platelets/ml and warmed to 37"C before experimentation. Serotonin 
secretion time courses were performed as previously described (9). 
Preparation of Cytoskeletal Cores:  Platelet aliquots  were acti- 
vated, with stirring at 37"C to give full aggregation, by Con A (100 #g/ml) or 
thrombin (l  U/ml) with and without  pretreatment  for 5-10  rain with CB (5 
;zg/ml) or pretreatment  with PGEt (1  #g/ml).  In studies involving exogenous 
fibrinogen,  human fibrinogen (purified  and  characterized  as previously  de- 
scribed [ 10]) in HEPES-buffered saline was added to a final concentration  of 
0.1  mg/ml before activation with thrombin. Cytoskeletal cores were extracted 
as described previously (9) and were pelleted from the extraction  mixture  by 
centrifugation at 10,000 g for 5 min at 0-4"C. Samples containing exogenous 
fibrinogen were subjected to two additional detergent washes before denatura- 
tion. 
DNase I-Actin  Inhibition  Assays:  Total  actin content  of whole 
platelet lysates and cytoskeletal cores was determined  after depolymerization 
in guanidine buffer as previously described (9). 
SDS Polyacrylamide Gel Electrophoresis:  Cytoskeletalcorepel- 
lets from 0.5 ml of  platelets ( 5 x  108/ml) were denatured with 0.5 ml of  onefold- 
concentrated denaturing  solution consisting of 2% sodium dodecyl sulfate, 2% 
2-mercaptoethanol,  10% glycerol, 3 mM EDTA,  12 mM EGTA, 0.01% brom- 
ophenol blue, and 50 mM Tris-HCI (pH 6.8). A 0.4-ml aliquot of the super- 
natant samples was treated with 0.1  ml of a fivefold-concentrated denaturing 
buffer. Total platelet protein  was prepared  by mixing a 0.2-ml aliquot of the 
platelet suspension with 0.1  ml of the threefold-concentrated  denaturing  solu- 
tion.  All samples were incubated  at  100*C for 3 min and electrophoresed on 
6-17.5 % polyacrylamide gradient SDS slab gels prepared as described by Studier 
(14). Staining and autoradiography were performed as previously described (9, 
10). A Bio-Rad high molecular weight standard  (Bio-Rad Laboratories) con- 
sisting of myosin,  beta-galactosidase, phosphorylase  A, BSA, and ovalbumin 
was included on each gel. Laser densitometric scanning was done with an LKB 
2202  ultrascan  densitometer  with an  LKB  2220 recording  integrator  (LKB 
Instruments, Inc., Gaithersburg, MD). 
Preparation of Samples for Electron Microscopy:  Platelets 
were activated with Con A (100 #g/ml) with and without  pretreatment  with 
CB (5 #g/ml) and with and without pre-exposure to PGE~ (/ #g/ml). Samples 
were  stirred  constantly  in  a  Payton  aggregometer  (Payton  Scientific  Inc., 
Buffalo, NY) maintained  at  37"C. Aliquots were removed at zero time,  at  5 
min, and at  l0 rain. The samples were fixed for  10-15 rain at 37"C with an 
equal  volume  of 0.1% glutaraldehyde  in  White's  saline  (15). Samples were 
further fixed overnight at room temperature  in 3% glutaraldehyde in White's 
saline, then for 90 min at 4"C in 1% osmium tetroxide in 15 mg/ml potassium 
ferricyanide. After fixation, the samples were washed twice with distilled water, 
then left overnight at 4"C in 3% uranyl acetate before dehydration  through a 
graded  series of ethanols  and  embedment  in  Spurr resin.  After  sectioning, 
samples  were  further  stained  using  0.2% lead citrate,  then  examined  and 
photographed using a Philips 400 EM transmission electron microscope (Philips 
Electronic Instruments,  Inc., Mahwah, N  J) at 80 kV. 
RESULTS 
Platelet Aggregation,  Secretion, and 
Cytoskeletal  Formation 
Con A induces the formation of a complete cytoskeleton 
(Fig. l, lane 3), similar to the thrombin-induced cytoskeleton 
(lane 2). The cytoskeletal core content of filamentous actin is 
slightly  reduced for activation with Con A  with respect to 
thrombin as assessed by DNase I inhibition assay (Table I). 
At I U/ml thrombin, maximal aggregation occurs between 2 
and 3 min, while activation by Con A follows a slower time 
course with maximal aggregation between 7 and 8 rain (Fig. 
2). The secretion of serotonin is also delayed with a maximum 
of 40% secretion at 5 min with Con A in contrast to maximal 
secretion with thrombin which occurs between 30 and 60 s 
followed by a I0-20% re-uptake (Fig. 3). 
When the cytosolic levels of cyclic AMP are elevated by 
pretreatment with PGEI or dibutyryl cyclic AMP sufficient to FIGURE  I  Polyacrylamide  gradient-SDS  gels of  concanavalin A- 
activated  platelets. Aliquots of  12Sl-surface labeled-platelets were 
activated and cytoskeletal cores prepared as described in Materials 
and  Methods.  Equivalent aliquots of  cytoskeletal core were sub- 
jected to electrophoresis on 6-I 7.5% polyacrylamide gradient-SDS 
slab  gels,  and  the  gels  were stained  with  Coomassie  Blue.  The 
cytoskeletal cores are  from:  (I)  control,  unaclivated  platelets; (2) 
platelets activated with  thrombin  (I  U/ml);  (3)  platelets activated 
with  Con  A  (100  ~.g/ml); (4)  platelets pretreated with  PGE~ (1  #g] 
ml), then activated with Con A; (5) platelets pretreated with CB (5 
#g/ml), then activated with Con A; (6) platelets pretreated with CB 
(5/~g/ml), then activated with thrombin (1  U/ml). The cytoskeletal 
components  indicated  are:  actin-binding  protein  (ABP), myosin 
heavy  chain  (MHC),  alpha-actinin  (a-A),  actin,  and  tropomyosin 
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FICURE  2  Aggregometer  tracing  of  platelet  aliquots.  Tracing  of 
aliquots  of  platelets  (5  x  108  platelets/ml) were obtained  as  de- 
scribed in Materials and Methods. Platelets were activated with 100 
ug]ml  Con  A  after  pretreatment with:  (A)  1  ~g]ml  PGE~; (B)  no 
pretreatment;  (C)  5  ug]ml  CB;  or  (D)  1  U/ml  thrombin.  Arrow 
indicates addition of activator. 
TABLE  I.  Cytoskeletal Core ComposiOon 
Treatment  Actin**  ABP*  Myosin*  GPIIIa  i 
Controls  <10%  <5%  <5%  <3% 
Thrombin  60-85  60-80  60-80  25 --. 1 
CB +  thrombin  40-50  6-14  62-70  <3% 
Con A  60-80  60-80  60-80  79 ±  4 
CB +  Con A  42-45  27-37  29-35  84 ±  5 
Con A +  PGE~  40-45  28-42  3-9  84 ±  5 
* Determined by laser densitometry of Coomassie Blue-stained bands (ABP, 
260-kD  actin-binding  protein; myosin  200-kD  heavy chain) resolved on 
SDS slab gels (n = 3). 
* Determined by DNase I inhibition assay (n = 3). 
s Determined  by laser densitometry of 12Sl-labeled  autoradiograms (± SEM, 
n= 5). 
m  Controls include unactivated platelets with and without pretreatment with 
CB or PGEI, platelet lysates  to which Con A or fibrinogen have been added 
before  pelleting,  and  platelets pretreated  with  PGEI before  addition of 
fibrinogen and thrombin. 
block cytoskeletal formation by thrombin, the pseudopodal 
cytoskeletal elements (actin cross-linked by actin-binding pro- 
tein and alpha-actinin) still form a precipitable matrix in the 
presence of Con A  (Fig.  1, lane 4) with only slight reduction 
in  the core content of actin.  This actin  in the core is most 
likely  that  filamentous  component  present  in  the  resting 
platelet (typically in the 30-40%  range) since no more than a 
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FIGURE  3  Secretion time course. Platelets were labeled with [14C3 
5-hydroxytryptamine as described in Materials and Methods. Sam- 
ples were activated at timer zero with I  U/ml thrombin (0); 100 ~g] 
ml Con A (O); pretreated with 5 #g/ml CB for 15 min at 37°C, then 
activated at time zero with Con A (II); pretreated with I #gJml PGE~ 
for 5 rain at 37°C before activation with Con A (A). 
DNase inhibition assays of whole platelet lysates. This precip- 
itation of an apparent pseudopodal cytoskeleton occurs even 
though platelet activation is also largely suppressed in terms 
of aggregation (Fig.  2),  secretion (Fig.  3), and actin-myosin 
interaction in the contractile gel (Fig.  1, lane 4). 
Pretreatment with CB enhances the Con A-induced aggre- 
gation  and  secretory responses,  as  has been  observed with 
other  activators  (9).  CB  pretreatment,  which  inhibits  the 
formation of the long actin filaments necessary for pseudo- 
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dal elements (actin-binding protein and alpha-actinin) from 
the Con A-stimulated cytoskeletal core (Fig.  1, lane 5). This 
is in contrast to the thrombin-induced cytoskeleton in which 
pretreatment with CB completely releases the actin-binding 
protein and a  significant quantity of the alpha-actinin from 
the cytoskeletal core (Fig. 1, lane 6). No additional precipitate, 
over control level, is observed (data not shown) if the Con A 
is added  after lysis  of the  unactivated  platelets.  This  is  in 
agreement with the results of Painter et al. (7). 
Electron Microscopy of Con A-activated Platelets 
Electron micrographs of unactivated controls, with or with- 
out PGE~ pretreatment, show discoidal platelets containing 
numerous randomly distributed granules (Fig. 4A). In agree- 
ment with the above results, at 5 min after stimulation with 
Con A, small aggregates of platelets exhibiting a loss of  discoid 
shape, granule centralization, degranulation, and pseudopodal 
formation are evident (Fig. 4, B and C). As has been previ- 
ously  noted  (5),  the  surface-connected  canalicular  system 
appears dilated and is more prominent than is typically ob- 
served with  other  activation conditions.  Pretreatment with 
CB followed by Con A activation produces a similar picture 
of activated platelets but with somewhat fewer pseudopodal 
projections (not shown). 
Platelets pretreated with PGEI and then exposed to Con A 
show some degree of cell-cell adherence by  l0 min but do 
not show any significant loss of discoid shape, granule cen- 
tralization, or degranulation (Fig. 4, D, E, and F). 
Phosphor)/lation of Platelet Proteins 
Activation  of platelets  by thrombin  has  been  shown  to 
induced rapid two- to threefold increases in phosphorylation 
of actin-binding protein (16) and myosin light chain (17), as 
well as of a  cytosolic 47,000-D protein (18)  designated 40P 
(5-10-fold) with peak 32P-labeling between 30 and 60 s. Ac- 
tivation with Con A produces similar increases in phospho- 
rylation of myosin light chain and 40P (Fig.  5A) (however, 
the phosphorylation of actin-binding protein is less than two- 
fold).  The  time  course,  like  the  aggregation  and  secretion 
response, is slower with peak 32p-labeling occurring between 
5  and  6  min.  Pretreatment  with  CB  followed  by  Con  A 
activation does  not  alter the  32p-labeling  pattern  (data  not 
shown). Pretreatment with PGE~ completely blocks the 32p_ 
labeling of  the myosin light chain (Fig. 5 B). The actin-binding 
protein, along with 24- and 22-kD peptides (19), is phospho- 
rylated  by  PGE~ independent  of activation  as  previously 
reported for PGI2 or dibutyryl cyclic AMP ( i l ). 
Cytoskeletal Core Content and Retention of 
Clycoprotein lib-Ilia 
Quantitation of the cytoskeletal cores of  the activated plate- 
lets by DNase I inhibition assay for actin content and laser 
densitometry of the Coomassie Blue-stained gels for myosin 
and actin-binding protein content is summarized in Table I. 
The effect of pretreatment with PGEj on Con A activation is 
a  slight reduction  in  cytoskeletal core actin  content  with  a 
significant decrease  in  myosin.  Pretreatment with  CB  pro- 
duces the same slight decrease in actin content  with either 
Con A or thrombin activation. The release of actin-binding 
protein from the core, under the influence of CB, is far greater 
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with thrombin activation than with Con A. 
Retention of the ~25I-labeled  glycoprotein IIb-IIIa  complex 
in the cytoskeletal cores was assessed by autoradiography and 
laser densitometry. The retention, expressed as a percentage 
of the whole platelet, was calculated using the glycoprotein 
Ilia band as a marker for the complex, since it is more heavily 
labeled and easier to quantitate.  In all platelet samples acti- 
vated with Con A, irrespective of pretreatment, the retention 
was in excess of 80%. Thrombin-activated platelet cores con- 
tained  25%  of the total glycoprotein IIb-IIIa complex, and 
pretreatment with  CB reduced the core content  to control 
levels. Similar data was previously reported for arachidonate- 
activated platelets, with or without pretreatment with CB (10). 
Cytoskeletal Formation and Glycoprotein lib-Ilia 
Retention in the Presence of Fibrinogen 
To  investigate  whether  the  multivalent  surface  binding 
provided by Con A might be responsible for retention of the 
pseudopodal elements in the presence of CB, platelets were 
activated with thrombin in the presence of 0.1  mg/ml exoge- 
nous fibrinogen (0.5  kD for fibrinogen-receptor binding). In 
addition to activating the platelets, thrombin will convert the 
soluble fibrinogen into the insoluble fibrin network. The fibrin 
network can then provide multiple sites for glycoprotein IIb- 
IIIa interaction. The cytoskeletal composition of ~25I-surface- 
labeled platelets activated with and without pretreatment with 
CB and in the presence or absence of exogenous fibrinogen 
are  shown  in  Fig.  6A.  The  autoradiogram  of the  retained 
surface-labeled protein is shown in Fig. 6 B. The cytoskeletal 
core from platelets activated with Con A (100 #g/ml) is shown 
in lane 1. In addition to retaining 79 + 4% of the glycoprotein 
IIb-IIIa  complex, other glycoproteins, including one ~ 140,000 
D  (possibly glycoprotein Ib), can be detected in these cores. 
Thrombin activation in the absence (lane 2) and presence of 
exogenous fibrinogen (lane 3) yield the same core composi- 
tions.  However,  the  retention  of the  glycoprotein  IIb-IIIa 
complex in the core is enhanced by the presence of exogenous 
fibrinogen  (Fig.  6B,  lanes  2  and  3).  Quantitation  by laser 
densitometry indicated that without exogenous fibrinogen, 25 
_+ 1% of the surface-labeled glycoprotein IIa is retained in the 
cytoskeletal core, whereas in the presence of exogenous fibrin- 
ogen,  36  _+  3%  of the  glycoprotein  IIIa is  retained.  CB- 
pretreated platelets activated without exongenous flbrinogen 
do not contain a significant proportion of actin-binding pro- 
tein  (lane  4),  and  the  core  content  of glycoprotein Ilia  is 
reduced to control levels (<3%). In the presence of fibrinogen, 
the cytoskeletal cores from CB-pretreated platelets activated 
by thrombin contain  a  significant  portion  of actin-binding 
protein (lane 5), and the retention of the glycoprotein IIIa in 
the core is increased 10-fold (31 _+ 3%). 
As with Con A, the addition of a similar amount of fibrin- 
ogen to the lysates of unactivated platelets does not increase 
the  levels of any  retained  core  component,  including  the 
glycoprotein IIb-IIIa  complex (Table I). This control demon- 
strates the need for an intact membrane surface-cytoskeletal 
system for these interactions to take place. In addition, plate- 
lets,  exposed to thrombin and fibinogen after pretreatment 
with PGEI to block activation, do not show increased reten- 
tion of cytoskeletal core components. This latter finding dem- 
onstrates the  need  for platelet activation expressing the  fi- 
brinogen binding site in order for the transmembrane cyto- 
skeletal interaction with the fibrin network to occur. FIGURE  4  Electron micrographs of Con A  activated with platelets. Platelets were either unactivated controls (A); activated with 
100 ~,g/ml Con A  for 5 min (B); activated with  100/~gJml Con A for 10 min (C); or pretreated for 10 min with  1 #g/ml PGE1, then 
activated with Con A for 10 rain (D, E, and F). Bar, 1 /~m. 
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etons and retention of surface-labeled  membrane proteins.  Equiv- 
alent aliquots of platelets were subjected  to electrophoresis on 6- 
17.5%  polyacrylamide gradient-SDS slab gels, and the gels were 
stained for protein with Coomassie Blue (A). Cytoskeleton was from: 
(1)  platelets  activated  with  100 /~g/ml Con  A;  (2) after  activation 
with 1 U/ml thrombin; (3) activation with  t  U/ml thrombin in the 
presence of 0.1  mg/ml fibrinogen; (4) pretreated  with CB, activated 
with 1 U/ml thrombin; (5) pretreated  with CB, activated with 1 U/ 
ml  thrombin  in  the  presence  of  0.1  mg/ml  fibrinogen.  B  is  the 
autoradiogram  of the protein-stained gel in A showing retention of 
the 12Sl-surface labeled  proteins,  lib,  glycoprotein lib; Ilia, glycopro- 
tein Ilia. 
FIGURE  5  Autoradiograms  of  32P-labeled  platelets.  32P-labeled 
platelets  were activated with  100 #g/ml  Con  A  (A) or  pretreated 
with 1 #g/ml PGE,, then activated with 100 #g/ml Con A (B). Whole 
platelet aliquots were denatured at time (min)  indicated. Samples 
were electrophoresed and autoradiographed as described  in Ma- 
terials in Methods. (ABP) Actin-binding protein; (40P) 47-kD protein; 
(MLC) myosin light chain; (22P) 22-kD  phosphoprotein; (24P)  24- 
kD phosphoprotein. 
DISCUSSION 
The activation of platelets by Con A has been suggested to be 
an analogue of  the normal receptor-mediated activation path- 
way (6). In agreement with this, we have shown that Con A 
activates human platelets, initiating phosphorylation, secre- 
tion, and the formation of a cytoskeletal structure that con- 
tains all  the  structural elements found in  the thrombin  or 
arachidonate-activated platelet. 
Platelet stimulus-response coupling is most likely mediated 
by increased phospholipid metabolism (20). The subsequent 
phospholipase C-mediated formation of diacylglycerol leads 
to activation of protein kinase C  (21,  22).  Protein kinase C 
phosphorylation of actin-binding protein (23)  may regulate 
its cross-linking of filamentous actin into a pseudopodal cy- 
toskeleton (16,  24).  At the same time, formation of throm- 
boxane A2 from the arachidonic acid metabolic pool, lyso- 
phosphatidic acid, and/or inositol  l, 4,  5-trisphosphate mo- 
bilizes calcium from the intracellular pool (25-28). Cytosolic 
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calcium-mediated phosphorylation of the myosin light chain 
stimulates the actin-myosin interaction (29) and the contrac- 
tile activity responsible for granule centralization (9). 
This entire process of actin polymerization and interaction 
with actin-binding protein and myosin is both blocked and 
even reversed by cyclic AMP inhibition of the elevation of 
cytosolic calcium triggered by thrombin or arachidonic acid 
(10-12). Unlike these activators, Con A precipitates pseudo- 
podal  (actin-tropomyosin, alpha-actinin,  and  actin-binding 
protein) core components along with most of  the glycoprotein 
IIb-IIIa complex in the presence of PGE~ or dibutyryl cyclic 
AMP. Under the influence of PGE~ or dibutyryl cAMP, Con 
A cannot stimulate phosphorylation of the 20-kD light chain, 
and the actin-myosin interaction is blocked. 
To explain these results,  we propose the following model. 
In the unactivated platelet, it is now generally accepted that 
~60-70% of the platelet actin is in a monomeric actin pool 
(9,  10, 30), perhaps stabilized by profilin (31). The organiza- 
tion and  subcellular distribution of the remaining  30-40% 
actin is not known but has been proposed to be an unorga- 
nized or amorphous network (30, 32), possible associated with 
the platelet membrane (33,  34). This actin may be in short 
filaments, the ends of which could serve as nucleation sites, 
and are blocked by capping proteins (35).  In our model, the 
monomeric actin pool is induced to polymerize by receptor 
occupancy uncapping of these nucleation sites on the mem- 
brane or by formation of de novo membrane or cytoplasmic 
nucleation  sites.  Regulation  of this  latter  process may  be 
accomplished by elevation of  cytoplasmic calcium levels caus- 
ing  actin  nucleation  by  gelsolin  (36,  37)  or,  perhaps,  by 
phosphorylation of  cytoskeletal proteins such as actin-binding protein (16,  38).  That long actin filaments can form in the 
presence of gelsolin and micromolar calcium is, perhaps, due 
to the stabilizing influence of tropomyosin (39), also a com- 
ponent of the platelet cytoskeleton (40). 
The cytoskeletal proteins incorporated into the  Con  A- 
stimulated cytoskeleton are the same as in the cores recovered 
from platelets activated with thrombin or arachidonate. How- 
ever, we suggest that activation may be initiated by an altered 
mechanism. The binding of Con A to the surface glycopro- 
reins may collect or cap the receptors, resulting in linkage and 
clustering of polymerized actin (41).  This membrane-associ- 
ated actin could bind alpha-actinin and actin-binding protein 
on  the  cytosolic face of the  plasma  membrane (34).  This 
rearrangement of membrane proteins may also displace cal- 
cium from the plasma membrane and initiate phospholipid 
metabolism resulting in diacylglycerol-mediated protein ki- 
nase C  activation and  cytosolic calcium-mediated myosin 
kinase  activation.  This,  coupled with  actin  polymerization 
triggered by one of the above mechanisms, leads to assembly 
of the complete cytoskeletal system. 
An apparent cytoskeletal core was precipitated by Con A 
despite cyclic AMP elevation and inhibition of platelet acti- 
vation in terms of shape change, phosphorylation of 40P and 
myosin light chain,  contractile gel  core formation, granule 
centralization, and secretion. Our interpretation of this result 
is that we are precipitating membrane-associated complexes 
of actin-tropomyosin, alpha-actinin, and actin-binding pro- 
tein already present in the unactivated platelet. A less likely 
alternative is that these complexes form in the presence of 
Con A despite cyclic AMP opposition of cytosolic calcium 
elevation and protein phosphorylation. Although this latter 
possibility could be analogous to the  receptor occupancy- 
triggered cytoskeletal assembly model mentioned above, we 
did  not  observe  more than  a  5-10%  de  novo  increase  in 
filamentous actin  in  the whole platelet lysates under these 
conditions. The actin content of the core collected by Con A 
in the presence of PGE~ is, most likely, the preexisting pool 
of 30-40% filamentous actin present in the resting platelet. 
This would be consistent with a recent finding that a subpop- 
ulation of glycoprotein IIb-IIIa is associated with actin in the 
resting platelet (42). 
Actin-binding protein, although phosphorylated by cyclic 
AMP elevation independent of  activation, was not extensively 
phosphorylated during Con A activation despite almost nor- 
mal levels of 40P and myosin light chain phosphorylation. 
Since actin-binding protein was retained in the isolated cyto- 
skeletal  core  to  the  same  extent  as  with  other  activators 
causing extensive actin-binding protein phosphorylation (9, 
16), these results may argue against an obligatory role for such 
phosphorylation during activation to initiate cytoskeletal in- 
teractions. However, it should be noted that the mechanism 
by which Con A is collecting the actin-binding protein may 
not  be the  same as activation-dependent formation of the 
pseudopodal cytoskeleton. With respect to this possibility,  it 
has been recently reported that actin-binding protein may be 
associated  in  the  unactivated platelet with  glycoprotein Ib 
(43), a possible component of the Con A cytoskeletal cores. 
The behavior of the apparent pseudopodal core from Con 
A-activated platelets also  differs from thrombin- or arachi- 
donate-treated platelets with respect to sensitivity to CB. With 
these typical activators, CB may inhibit the formation of long 
actin filaments necessary for pseudopodal formation (9,  10). 
The cytoskeletal cores contain actin (presumably short ilia- 
ments) and myosin, but the content of actin-binding protein 
is substantially reduced. However, in Con A-activated plate- 
lets, the extensive Con A cross-linking of  the glycoprotein IIb- 
IIIa complex on the surface allows the actin-binding protein- 
alpha- actinin - filamentous  actin - tropomyosin  - membrane 
complex to  be  precipitated despite  CB  pretreatment.  The 
simplest explanation for this result is our previous suggestion 
(10) that the glycoprotein IIb-IIIa linkage to this cytoskeletal 
complex remains intact in the presence of CB. While Con A 
may not organize these complexes into the same pseudopodal 
cytoskeletal organization, its external cross-linking of these 
complexes substitutes for the lack of long actin filaments and 
insufficient cross-linking by actin-binding protein and alpha- 
actinin. 
The contribution of  the surface cross-linking to the recovery 
of glycoprotein IIb-IIIa and actin-binding protein in the core 
is further illustrated by the increased retention of the actin- 
binding protein-filamentous actin-glycoprotein IIb-IIIa 
membrane complex in cytoskeletal cores from platelets acti- 
vated  by thrombin  in  the  presence of the  forming  fibrin 
strands despite CB pretreatment. The fibrinogen-fibrin clot 
provides the equivalent of an external network of multivalent 
ligands  (44).  In contrast to Con A multivalent binding, the 
formation of the glycoprotein IIb-IIIa binding sites for fibrin- 
ogen/fibrin is dependent on activation and sensitive to cyclic 
AMP inhibition (45). 
The identity of the cytoskeletal component(s) linking the 
glycoprotein IIb-IIIa to the cytoskeleton is as yet unknown 
(46). That extensive cross-linking of the glycoprotein IIb-IIIa 
complex by an  external ligand  network, generated by two 
very different multivalent ligands,  retains the actin-binding 
protein-alpha-actinin-filamentous actin-tropomyosin com- 
plex in the cytoskeletal core despite the disruption by CB of 
the  internal  cytoskeletal network  illustrates  the  reciprocal 
nature of these multivalent interactions and the specificity of 
the glycoprotein llb-IIIa link to the platelet cytoskeleton. 
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